Should You Buy Microsoft Stock Now That It's Back Within 6% of Its Record?

Microsoft shares rebounded about 46% from their June 25 low of $352.83 to roughly $516 after Azure revenue growth accelerated to 43% in the June quarter, prompting a 26% gain in the four trading days after its July 29 earnings report. Azure is guided to grow 44%-45% in the September quarter, but AI-related capital expenditures rose 69% year over year to $41 billion and are expected to increase again in fiscal 2027. Free cash flow fell 23% to $19.6 billion in the June quarter, while OpenAI accounted for $24.1 billion of fiscal 2026 revenue, leaving the stock viewed as fairly priced at roughly 29x fiscal 2026 earnings.

Analysis

The key investable question is no longer cloud demand but conversion: incremental capacity must continue to translate into revenue quickly enough to prevent depreciation, leases, and power costs from absorbing the gross-profit benefit. A sustained Azure growth rate above 44%-45% would likely drive FY27 revenue-estimate revisions, but equity upside is capped unless management also demonstrates that free-cash-flow conversion has bottomed. The next earnings print is therefore a higher-quality catalyst for cash-flow-sensitive investors than for headline revenue momentum buyers.

Microsoft's aggressive infrastructure build is a favorable demand signal for AI supply-chain beneficiaries, particularly NVDA, ANET and VRT, but it also raises the risk that hyperscaler capex becomes increasingly debt/lease-funded before enterprise AI workloads mature. The market should distinguish capacity utilization from durable end-customer ROI: rapid initial monetization can reflect constrained supply and large model-provider commitments rather than broad enterprise adoption. Any deterioration in OpenAI funding access, compute procurement, or contract economics would disproportionately pressure MSFT's AI narrative even if its diversified cloud base remains intact.

Consensus appears too focused on the apparent valuation discount versus the prior peak and insufficiently focused on the change in valuation framework. As capex rises, investors may migrate from EPS-based valuation toward FCF yield and return-on-invested-capital, limiting multiple expansion despite strong reported earnings. Conversely, two consecutive quarters of Azure growth at or above guidance alongside sequential FCF improvement would falsify the cash-conversion concern and support a renewed premium multiple over AMZN and GOOGL.

Key Decisions for Investors

• Maintain MSFT at benchmark weight into the next earnings release; do not chase near prior highs. Upgrade to overweight only if Azure growth is at least 44%-45% and quarterly free cash flow turns sequentially positive despite elevated investment, targeting a 6-12 month move through the prior high. A sub-42% Azure result or another material FCF decline is the thesis failure signal.
• For defined-risk event exposure, buy a 3-4 month MSFT $540/$590 call spread only after confirmation that Azure guidance remains at or above 44%; this captures estimate-revision upside while recognizing that FCF concerns may constrain a breakout. Avoid naked calls before the report given asymmetric downside from a utilization or capex surprise.
• Express the AI-infrastructure read-through via a 3-6 month long NVDA or VRT position rather than adding MSFT beta immediately; their revenue sensitivity to sustained hyperscaler deployment is more direct. Size modestly and reduce if Microsoft signals fiscal-2027 capex growth is being deferred rather than reallocated, as that would challenge broader AI hardware demand expectations.
• Set an alert on disclosure of lease liabilities, depreciation growth, and OpenAI-related receivables/commitments at the next filing. A widening gap between reported operating income and free cash flow, or evidence that AI capacity is being monetized through concentrated counterparties, would support a tactical MSFT underweight versus GOOGL.